The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kelly James Patrick since year 2005.
The trader's CIK number is 1506314.
At the time of this reporting, Kelly James Patrick is the EVP & Chief Financial Officer of Vanda Pharmaceuticals Inc. .
(stock ticker symbol VNDA).
See this page for all insider trading activities at Vanda Pharmaceuticals Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-03-01||VNDA||Vanda Pharmaceuticals Inc.||Sale||8,532||18.72||159,710|
|2018-01-02||VNDA||Vanda Pharmaceuticals Inc.||Option Ex||17,500||.00||0|
|2018-01-02||VNDA||Vanda Pharmaceuticals Inc.||Sale||9,155||15.35||140,492|
|2017-01-03||VNDA||Vanda Pharmaceuticals Inc.||Option Ex||19,844||.00||0|
|2017-01-03||VNDA||Vanda Pharmaceuticals Inc.||Sale||10,895||15.51||169,014|
|2016-01-04||VNDA||Vanda Pharmaceuticals Inc.||Option Ex||17,032||.00||0|
|2016-01-04||VNDA||Vanda Pharmaceuticals Inc.||Sale||9,564||8.96||85,693|
|2015-03-10||VNDA||Vanda Pharmaceuticals Inc.||Option Ex||24,531||.00||0|
|2015-03-10||VNDA||Vanda Pharmaceuticals Inc.||Sale||12,450||10.53||131,098|
|2014-02-18||VNDA||Vanda Pharmaceuticals Inc.||Option Ex||19,531||.00||0|
|2013-11-19||VNDA||Vanda Pharmaceuticals Inc.||Sale||3,348||12.07||40,420|
|2013-07-29||VNDA||Vanda Pharmaceuticals Inc.||Option Ex||9,375||.00||0|
|2013-02-14||VNDA||Vanda Pharmaceuticals Inc.||Option Ex||17,187||.00||0|
|2012-02-16||VNDA||Vanda Pharmaceuticals Inc.||Option Ex||12,500||.00||0|
|2012-02-16||VNDA||Vanda Pharmaceuticals Inc.||Sale||4,920||4.67||22,996|
|2011-08-29||VNDA||Vanda Pharmaceuticals Inc.||Buy||5,000||5.99||29,950|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelly James Patrick (EVP & Chief Financial Officer of Vanda Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.